Shana O Warner
Overview
Explore the profile of Shana O Warner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Warner S, Dai Y, Sheanon N, Yao M, Cason R, Arbabi S, et al.
JCI Insight
. 2023 May;
8(12).
PMID: 37166980
Fasting is associated with increased susceptibility to hypoglycemia in people with type 1 diabetes, thereby making it a significant health risk. To date, the relationship between fasting and insulin-induced hypoglycemia...
2.
Moore M, Warner S, Dai Y, Sheanon N, Smith M, Farmer B, et al.
JCI Insight
. 2021 May;
6(12).
PMID: 34003799
Several studies have associated the presence of residual insulin secretion capability (also referred to as being C-peptide positive) with lower risk of insulin-induced hypoglycemia in patients with type 1 diabetes...
3.
Warner S, Wadian A, Smith M, Farmer B, Dai Y, Sheanon N, et al.
Am J Physiol Endocrinol Metab
. 2021 Mar;
320(5):E914-E924.
PMID: 33779306
Iatrogenic hypoglycemia is a prominent barrier to achieving optimal glycemic control in patients with diabetes, in part due to dampened counterregulatory hormone responses. It has been demonstrated that elevated liver...
4.
Warner S, Yao M, Cason R, Winnick J
Front Endocrinol (Lausanne)
. 2020 Sep;
11:567.
PMID: 32982968
Type 2 diabetes (T2D) is a metabolic disease characterized by obesity, insulin resistance, and the dysfunction of several key glucoregulatory organs. Among these organs, impaired liver function is recognized as...
5.
Thomas T, Warner S, Dellsperger K, Hinton P, Whaley-Connell A, Rector R, et al.
J Appl Physiol (1985)
. 2010 Feb;
109(1):3-10.
PMID: 20167668
Weight loss improves metabolic syndrome (MetS) factors, but risk may return with weight regain. This study was designed to determine if exercise training can maintain improvements in MetS risk factors...
6.
Warner S, Linden M, Liu Y, Harvey B, Thyfault J, Whaley-Connell A, et al.
J Clin Hypertens (Greenwich)
. 2010 Jan;
12(1):64-72.
PMID: 20047634
To determine whether resistance training effectively maintains improvements in cardiometabolic syndrome risk factors during weight regain, 9 individuals lost 4% to 6% of their body weight during an 8- to...
7.
Rector R, Linden M, Zhang J, Warner S, Altena T, Smith B, et al.
J Clin Hypertens (Greenwich)
. 2009 Nov;
11(11):663-71.
PMID: 19878381
To determine whether a single-point triglyceride (TG) concentration could estimate the 8-hour postprandial lipemic (PPL) response, men and women performed baseline PPL (n=188) and postexercise PPL (n=92) trials. Correlations were...
8.
Laye M, Rector R, Warner S, Naples S, Perretta A, Uptergrove G, et al.
J Physiol
. 2009 Jun;
587(Pt 14):3729-39.
PMID: 19491243
Using the hyperphagic, obese, Otsuka Long-Evans Tokushima Fatty (OLETF) rat, we sought to determine if progression to type 2 diabetes alters visceral white adipose tissue (WAT) mitochondrial content and if...
9.
Rector R, Warner S, Liu Y, Hinton P, Sun G, Cox R, et al.
Am J Physiol Endocrinol Metab
. 2007 May;
293(2):E500-6.
PMID: 17473052
Obesity and insulin resistance (IR) increase the risk for coronary heart disease; however, much of this risk is not attributable to traditional risk factors. We sought to determine whether weight...